
GnT-V Antibody (3E9) is a mouse monoclonal IgG2a kappa light chain antibody that detects GnT-V protein of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). Anti-GnT-V antibody (3E9) is available as the non-conjugated format. UDP-N-acetylglucosamine:α mannoside β1,6 N-acetylglucosaminyltransferase, commonly referred to as GnT-V, is crucial for modifying N-linked glycoproteins, which significantly impacts cellular functions and disease processes, particularly in cancer. GnT-V (3E9) antibody recognizes the protein primarily in the Golgi apparatus, where GnT-V facilitates GlcNAc residue addition to glycoproteins - a modification essential for proper protein folding, stability, and function. This Golgi localization ensures glycoproteins are correctly processed before transport to final destinations, influencing cell signaling and interactions. GnT-V expression increases in various cancers, including hepatocellular carcinoma, contributing to tumor progression and metastasis. Regulation of GnT-V by transcription factors involved in angiogenesis and tumor cell invasion highlights GnT-V′s role in cancer biology, making GnT-V a potential target for therapeutic intervention.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.
Download thiomersal SDS
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GnT-V Antibody (3E9) | sc-293276 | 100 µg/ml | $322.00 | |||
GnT-V Antibody (3E9): m-IgG Fc BP-HRP Bundle | sc-540282 | 100 µg Ab; 10 µg BP | $361.00 | |||
GnT-V Antibody (3E9): m-IgG2a BP-HRP Bundle | sc-546886 | 100 µg Ab; 10 µg BP | $361.00 |